Clinical trials and clinical practice ‐ bridging the gaps in type 2 diabetes. An evidence‐based approach to risk factor modification in type 2 diabetes

Publisher： John Wiley & Sons Inc

E-ISSN： 1445-5994|30|4|483-491

ISSN： 1444-0903

Source： INTERNAL MEDICINE JOURNAL, Vol.30, Iss.4, 2000-08, pp. : 483-491

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Incorporating Incretin-Based Therapies into Clinical Practice for Patients with Type 2 Diabetes

By Tibaldi Joseph  

Advances in Therapy, Vol. 31, Iss. 3, 2014-03 ,pp. : 289-317

Springer Publishing Company

Access to resources Recommend Favorite

Clinical evaluation of combined therapy for type 2 diabetes

By Rodríguez Ángel   Ciprés Luis   Tofé Santiago   Polavieja Pepa   Reviriego Jesús  

Current Medical Research and Opinion, Vol. 26, Iss. 5, 2010-05 ,pp. : 1171-1183

Informa Healthcare

Access to resources Recommend Favorite

Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials

By Karasik Avraham   Aschner Pablo   Katzeff Harvey   Davies Michael J.   Stein Peter P.  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 489-496

Informa Healthcare

Access to resources Recommend Favorite

Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 3, 2018-03 ,pp. : 620-628

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is Exenatide Improving the Treatment of Type 2 Diabetes? Analysis of the Individual Clinical Trials with Exenatide

By  

Reviews on Recent Clinical Trials, Vol. 2, Iss. 1, 2007-01 ,pp. : 77-84

Bentham Science Publishers

Access to resources Recommend Favorite